Evidence map›Paper›PMID 31069457›Full record

ArticleEuropean journal of nutrition2020

Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).

Trinidad Dierssen-Sotos, Inés Gómez-Acebo, Camilo Palazuelos, Esther Gracia-Lavedan, Beatriz Pérez-Gómez, Madalen Oribe, Vicente Martín, Marcela Guevara, Paz Rodríguez-Cundín, Guillermo Fernández-Tardón and 12 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Obesity as a Risk Factor for Breast Cancer-The Role of miRNA.International journal of molecular sciences · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 1 country.

Trinidad Dierssen-SotosConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain. dierssent@unican.es.ORCID http://orcid.org/0000-0002-6127-0077
Inés Gómez-AceboConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Camilo PalazuelosFacultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.
Esther Gracia-LavedanConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Beatriz Pérez-GómezConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Madalen OribePublic Health Division of Gipuzkoa, Health Department, BioDonostia Research Institute, San Sebastian, Basque Country, Spain.
Vicente MartínInstituto de Biomedicina (IBIOMED), Universidad de León, León, Spain.
Marcela GuevaraInstituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.
Paz Rodríguez-CundínServicio de Medicina Preventiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Guillermo Fernández-TardónIUOPA, Universidad de Oviedo, Asturias, Spain.
Rafael Marcos-GrageraResearch Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.
Ana Molina-BarcelóCancer and Public Health Area, FISABIO-Public Health, Valencia, Spain.
Marian Díaz-SantosCentro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain.
Gemma Castaño-VinyalsConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Nuria AragonésEpidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.
Ana López-GonzalezServicio de Oncología, Complejo Asistencial Universitario de León, León, Spain.
Pilar AmianoConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Jesús CastillaConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Jessica Alonso-MoleroFacultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.
Manolis KogevinasConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Marina PollánConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Javier LlorcaConsortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Universidad de Cantabria · ESUniversitat Pompeu Fabra · ESBiogipuzkoa Health Research Institute · ESInstituto de Salud Pública de Navarra · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESComplejo Asistencial Universitario de Palencia · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESGeneralitat de Catalunya · ESInstituto de Salud Carlos III · ESMarqués de Valdecilla University Hospital · ESUniversidad de Huelva · ESUniversidad de León · ESUniversidad de Oviedo · ES

Funding

Instituto de Salud Carlos III (ES) PI08/0533Instituto de Salud Carlos III (ES) PI08/1359Instituto de Salud Carlos III (ES) PI09/00773-CantabriaInstituto de Salud Carlos III (ES) PI09/01286-LeónInstituto de Salud Carlos III (ES) PI09/01662-GranadaInstituto de Salud Carlos III (ES) PI09/01903-ValenciaInstituto de Salud Carlos III (ES) PI09/02078-HuelvaInstituto de Salud Carlos III (ES) PI11/00226Instituto de Salud Carlos III (ES) PI11/01403Instituto de Salud Carlos III (ES) PI11/01810Instituto de Salud Carlos III (ES) PI11/01889-FEDERInstituto de Salud Carlos III (ES) PI11/02213Instituto de Salud Carlos III (ES) PI12/00150Instituto de Salud Carlos III (ES) PI12/00265Instituto de Salud Carlos III (ES) PI12/00488Instituto de Salud Carlos III (ES) PI12/00715Instituto de Salud Carlos III (ES) PI12/01270Instituto de Salud Carlos III (ES) PI14/01219Instituto de Salud Carlos III (ES) PI14/0613Instituto de Salud Carlos III (ES) PI15/00069Instituto de Salud Carlos III (ES) PI15/00914Instituto de Salud Carlos III (ES) PI15/01032The Fundación Marqués de Valdecilla API 10/09
6 · The paper itself

Abstract

purposeTo evaluate the association between dietary fat and fat subtype and breast cancer development.

methodsWe conducted a case-control study with 1181 cases of incident breast cancer, diagnosed between 2007 and 2012, and 1682 population controls frequency matched (by age, sex, and region) from the Spanish multicenter case-control study MCC-Spain.

resultsWe found a significant protective effect in premenopausal women of total fat intake [OR 0.51 95% CI (0.31-0.86) highest versus lowest tertile], but no effect was observed in menopausal women [OR 1.15 95% CI (0.83-1.60)]. Analyzing by type of fat, this protective effect persisted only for the monounsaturated fatty acids [OR 0.51 95% CI (0.32-0.82)]. In contrast, other fatty acids did not have a significant effect. In addition, a protection against risk of breast cancer was found when polyunsaturated fats were "substituted" by monounsaturated, maintaining the same total fat intake [OR 0.68 95% CI (0.47-0.99)]. Finally, analyzing by breast cancer subtype, we found no effect, except in premenopausal women where intake of moderate [OR 0.52 95% CI (0.33-0.82)] and high monounsaturated fatty acids [OR 0.47 95% CI (0.27-0.82)] maintains a protective effect against ER/PR + tumors. In contrast, in menopausal women, a high intake of monounsaturated fatty acids was associated with higher risk of HER2 + tumors [OR 2.00 95% CI (0.97-4.13)].

conclusionOur study shows a differential effect of monounsaturated fatty acids according to menopausal status and breast cancer subtype.

Indexed as

Breast NeoplasmsCase-Control StudiesDietary FatsFatty AcidsFemaleHumansMiddle AgedSpainDietary FatsFatty AcidsBreast cancerDietary fatFatty acid intakeMCC-SpainMonounsaturated fatPolyunsaturated fatSaturated fat

Identifiers

PMID31069457
OpenAlexW2944074088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.